Beta-cryptoxanthin (BCX)

Beta-cryptoxanthin is a naturally occurring xanthophyll carotenoid and a significant provitamin A precursor found primarily in citrus fruits such as oranges and tangerines, as well as in papayas and red peppers (PubChem CID 5281235). It is enzymatically converted into vitamin A (retinol) via cleavage by beta-carotene oxygenase 1 (BCO1) in the intestinal mucosa, contributing to the maintenance of healthy vision and immune function (NIH Office of Dietary Supplements). Beyond its role as a nutrient, beta-cryptoxanthin exhibits potent antioxidant properties and has been specifically noted for its unique ability to promote bone health by stimulating osteoblastic bone formation and inhibiting osteoclastic bone resorption (Yamaguchi, M., 2012). The provided name, 'Beta-cryptoxanthin bioavailability,' refers to the pharmacokinetic property regarding the efficiency of its absorption rather than a biological molecule or therapeutic target; however, beta-cryptoxanthin itself is a vital micronutrient that is often more bioavailable than other provitamin A carotenoids like beta-carotene (Burri, B. J., 2015). It is not targeted by therapeutic drugs, although its systemic levels can be significantly reduced by medications that inhibit fat absorption, such as orlistat or bile acid sequestrants.

Other names

(3R)-beta,beta-caroten-3-olCryptoxanthinBeta-cryptoxantholall-trans-beta-cryptoxanthinProvitamin A

Beta-cryptoxanthin is not a traditional drug target; it serves as a substrate for beta-carotene 15,15'-monooxygenase (BCO1), which cleaves it to produce one molecule of retinal, subsequently converted to retinol (Vitamin A). It also acts as an antioxidant by scavenging singlet oxygen and neutralizing free radicals.